Adjuvant and neoadjuvant therapy for early stage: Non-small cell lung cancer

Seminars in Oncology

Volumn 28, Issue 4 SUPPL. 14, 2001, Pages 23-28

  Pisters, Katherine M W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BCG VACCINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; LEVAMISOLE; MITOMYCIN; PACLITAXEL; TEGAFUR; UFT; VINDESINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INDUCED DISEASE; HUMAN; IMMUNOTHERAPY; LUNG NON SMALL CELL CANCER; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034790612     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.27612     Document Type: Article

References (21)

1. Revisions in the international system for staging lung cancer
2. Surgical adjuvant therapy for stage 11 and stage 111 adenocarcinoma and large-cell undifferentiated carcinoma
3. The benefit of adjuvant treatment for resected locally advanced non-small cell lung cancer
4. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I NSCLC
5. Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: A randomized study
6. Adjuvant chemotherapy for completely resected stage III non-small cell lung cancer. Results of a randomized prospective study
7. Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer
8. A randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIa non-small cell lung cancer
9. A randomized controlled trial of postoperative adjuvant chemotherapy in non-small cell lung cancer
10. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study)
11. Adjuvant chemotherapy after complete resection in non-small cell lung cancer
12. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
13. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small cell lung cancer: Results of the Toronto phase II trial
14. Neoadjuvant cisplatin and etoposide for stage IIIA (clinical N2) non-small cell lung cancer
15. Preoperative chemotherapy for stage IIIA (N2) lung cancer: The Memorial Sloan-Kettering experience with 136 patients
16. Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced nonsmall cell lung cancer. Final report of phase 2 study
17. Pathologic complete response in advanced non-small cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small cell lung cancer combined modality trials
18. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: A 7-year assessment of a randomized controlled trial
19. Long-term followup of patients enrolled in a randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer
20. Phase III trial of neoadjuvant chemotherapy in resectable stage I (except T1N0), II, IIIA non-small cell lung cancer: The French experience
21. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach